Posters

  • D. Bates
  • J. French
  • S. Nightindale
  • D. Shaw
  • S. Hawkins
  • H. Millar
  • M. Sidey
  • A. Smith
  • R. Thompson
  • K. Zilka
  • M. Gale
  • H. Sinclair
  • J. E. Bauer
  • P. Schenck
  • C. H. Beauchamp
  • R. K. Berge
  • A. Aarsland
  • R. Clarke
  • A. Tobin
  • C. O’Morain
  • I. Graham
  • S. C. Cunnane
  • T. M. S. Wolever
  • J. K. Armstrong
  • D. J. A. Jenkins
  • Knut H. Dahl
  • G. Øi
  • H. E. Krokan
  • R. De Schrijver
  • B. Descomps
  • S. El Boustani
  • L. Monnier
  • F. Mendy
  • A. Crastes de Paulet
  • P. Green
  • J. Fuchs
  • P. Budowski
  • Y. Lurie
  • I. Beigel
  • J. Agmon
  • L. Leibovici
  • R. Mamet
  • N. Schoenfeld
  • G. Hornstra
  • R. van Houwelingen
  • J. Gerrard
  • H. Huisjes
  • L. Medini
  • S. Colli
  • E. Tremoli
  • C. Galli
  • C. Mosconi
  • M. Blasevich
  • M. Gianfranceschi
  • D. L. Puppione
  • R. J. Jandacek
  • S. T. Kunitake
  • D. P. Costa
  • H. W. Renner
  • D. S. Sgoutas
  • J. A. Hearn
  • K. A. Robinson
  • S. B. King
  • G. S. Roubin
  • Paul A. Stitt
  • B. H. Weiner

Abstract

A trial of n−3 polyunsaturated fatty acids in the treatment of multiple sclerosis has been conducted over a 5-year period. 312 ambulant patients with acute remitting disease were randomly allocated to treatment and placebo controlled groups. Both were given dietary advice to increase the intake of n−6 polyunsaturated fatty acids and the treatment group in addition received capsules containing n−3 polyunsaturated fatty acids. The results showed no significant difference at the usual 95% confidence level, but there was a trend in favour of the n−3 treated group in all parameters examined including rate of deterioration, frequency and severity of attacks and number of patients improving or remaining unchanged during the course of the trial.

Keywords

Inositol Phosphate Fatty Acid Supplementation Inuit Woman Erythrocyte Filtrability Glycerophosphate Acyltransferase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • D. Bates
    • 1
  • J. French
    • 1
  • S. Nightindale
    • 1
  • D. Shaw
    • 1
  • S. Hawkins
    • 2
  • H. Millar
    • 2
  • M. Sidey
    • 3
  • A. Smith
    • 3
  • R. Thompson
    • 3
  • K. Zilka
    • 3
  • M. Gale
    • 4
  • H. Sinclair
    • 4
  • J. E. Bauer
    • 5
  • P. Schenck
    • 5
  • C. H. Beauchamp
    • 5
  • R. K. Berge
    • 6
  • A. Aarsland
    • 6
  • R. Clarke
    • 7
  • A. Tobin
    • 7
  • C. O’Morain
    • 7
  • I. Graham
    • 7
  • S. C. Cunnane
    • 8
  • T. M. S. Wolever
    • 8
  • J. K. Armstrong
    • 8
  • D. J. A. Jenkins
    • 8
  • Knut H. Dahl
    • 9
  • G. Øi
    • 9
  • H. E. Krokan
    • 9
  • R. De Schrijver
    • 10
  • B. Descomps
    • 11
    • 12
  • S. El Boustani
    • 11
    • 12
  • L. Monnier
    • 11
    • 12
  • F. Mendy
    • 11
    • 12
  • A. Crastes de Paulet
    • 11
    • 12
  • P. Green
    • 13
  • J. Fuchs
    • 13
  • P. Budowski
    • 13
  • Y. Lurie
    • 13
  • I. Beigel
    • 13
  • J. Agmon
    • 13
  • L. Leibovici
    • 13
  • R. Mamet
    • 13
  • N. Schoenfeld
    • 13
  • G. Hornstra
    • 14
  • R. van Houwelingen
    • 15
  • J. Gerrard
    • 16
  • H. Huisjes
    • 17
  • L. Medini
    • 18
  • S. Colli
    • 18
  • E. Tremoli
    • 18
  • C. Galli
    • 18
    • 19
  • C. Mosconi
    • 19
  • M. Blasevich
    • 19
  • M. Gianfranceschi
    • 19
  • D. L. Puppione
    • 20
  • R. J. Jandacek
    • 20
  • S. T. Kunitake
    • 20
  • D. P. Costa
    • 20
  • H. W. Renner
    • 21
  • D. S. Sgoutas
    • 22
  • J. A. Hearn
    • 22
  • K. A. Robinson
    • 22
  • S. B. King
    • 22
  • G. S. Roubin
    • 22
  • Paul A. Stitt
    • 23
  • B. H. Weiner
    • 24
  1. 1.Newcastel upon TyneUK
  2. 2.BelfastUK
  3. 3.LondonUK
  4. 4.OxfordUK
  5. 5.University of Florida, College of Veterinary MedicineGainesvilleUSA
  6. 6.Laboratory of Clinical BiochemistryUniversity of BergenBergenNorway
  7. 7.Adelaide HospitalDublinIreland
  8. 8.Department of Nutritional SciencesUniversity of TorontoTorontoCanada
  9. 9.Norsk Hydro Research CentrePorsgrunnNorway
  10. 10.Laboratory of NutritionCatholic University of LeuvenLeuvenBelgium
  11. 11.INSERM U.58MontpellierFrance
  12. 12.Laboratoire de Biochemie A et Service des Maladies Metaboliques et Endocriniennes du CHR de MontpellierMontpellierFrance
  13. 13.Beilinson Medical CenterPetah TiqvaIsrael
  14. 14.Department of BiochemistryLimburg UniversityMaastrichtThe Netherlands
  15. 15.Department of Human BiologyLimburg UniversityMaastrichtThe Netherlands
  16. 16.Manitoba Institute of Cell BiologyWinnipegCanada
  17. 17.Department of Gynaecology and ObstetricsAcademic Hospital GroningenThe Netherlands
  18. 18.Institute of Pharmacological Sciences and Grossi-Paoletti Center for the Study of HyperlipidemiasUniversity of MilanMilanItaly
  19. 19.Institute of Pharmacological SciencesUniversity of MilanMilanItaly
  20. 20.Miami Valley LaboratoriesUniversity of California at Santa Cruz, Los Angeles and San Francisco; The Proctor and Gamble Co.USA
  21. 21.Federal Research Centre of NutritionKarlsruheGermany
  22. 22.Andreas Gruentzig Cardiovascular Center, Clinical Research Facility, and Department of Pathology and Laboratory MedicineEmory University School of MedicineAtlantaUSA
  23. 23.ENRECO/Essential Nutrient Research CompanyManitowocUSA
  24. 24.Cardiovascular MedicineUniversity of Massachusetts Medical SchoolWorcesterUSA

Personalised recommendations